DYNO MCAP Trademark

Trademark Overview


On Friday, June 9, 2023, a trademark application was filed for DYNO MCAP with the United States Patent and Trademark Office. The USPTO has given the DYNO MCAP trademark a serial number of 98035251. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, September 29, 2025. This trademark is owned by Dyno Therapeutics, Inc.. The DYNO MCAP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequen...
dyno mcap

General Information


Serial Number98035251
Word MarkDYNO MCAP
Filing DateFriday, June 9, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, September 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical and pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research for the treatment and prevention of gene therapy treatable diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDyno Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Party NameDyno Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Thursday, July 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 5, 2024ASSIGNED TO EXAMINER
Friday, April 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, April 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 13, 2023NEW APPLICATION ENTERED
Tuesday, February 13, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 13, 2024NON-FINAL ACTION E-MAILED
Tuesday, February 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 30, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, August 30, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 30, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, October 8, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, August 30, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, September 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2024PUBLISHED FOR OPPOSITION
Friday, December 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 6, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, May 6, 2025SOU EXTENSION 1 FILED
Wednesday, May 7, 2025SOU EXTENSION 1 GRANTED
Monday, September 29, 2025SOU EXTENSION 2 FILED
Monday, September 29, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 29, 2025SOU EXTENSION 2 GRANTED
Tuesday, September 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED